These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 10217316

  • 1. Possible influences of ginseng on the pharmacokinetics and pharmacodynamics of warfarin in rats.
    Zhu M, Chan KW, Ng LS, Chang Q, Chang S, Li RC.
    J Pharm Pharmacol; 1999 Feb; 51(2):175-80. PubMed ID: 10217316
    [Abstract] [Full Text] [Related]

  • 2. Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.
    Jiang X, Williams KM, Liauw WS, Ammit AJ, Roufogalis BD, Duke CC, Day RO, McLachlan AJ.
    Br J Clin Pharmacol; 2004 May; 57(5):592-9. PubMed ID: 15089812
    [Abstract] [Full Text] [Related]

  • 3. The alpha-glucosidase inhibitor voglibose (AO-128) does not change pharmacodynamics or pharmacokinetics of warfarin.
    Fuder H, Kleist P, Birkel M, Ehrlich A, Emeklibas S, Maslak W, Stridde E, Wetzelsberger N, Wieckhorst G, Lücker PW.
    Eur J Clin Pharmacol; 1997 May; 53(2):153-7. PubMed ID: 9403289
    [Abstract] [Full Text] [Related]

  • 4. The effects of Danshen (Salvia miltiorrhiza) on warfarin pharmacodynamics and pharmacokinetics of warfarin enantiomers in rats.
    Chan K, Lo AC, Yeung JH, Woo KS.
    J Pharm Pharmacol; 1995 May; 47(5):402-6. PubMed ID: 7494191
    [Abstract] [Full Text] [Related]

  • 5. Pharmacodynamics of warfarin in cats.
    Smith SA, Kraft SL, Lewis DC, Melethil S, Freeman LC.
    J Vet Pharmacol Ther; 2000 Dec; 23(6):339-44. PubMed ID: 11168910
    [Abstract] [Full Text] [Related]

  • 6. Puerarin offsets the anticoagulation effect of warfarin in rats by inducing rCyps, upregulating vitamin K epoxide reductase and inhibiting thrombomodulin.
    Ge B, Zhang Z, Lam TT, Zuo Z.
    Biopharm Drug Dispos; 2017 Jan; 38(1):33-49. PubMed ID: 27925234
    [Abstract] [Full Text] [Related]

  • 7. The effect of Kan Jang extract on the pharmacokinetics and pharmacodynamics of warfarin in rats.
    Hovhannisyan AS, Abrahamyan H, Gabrielyan ES, Panossian AG.
    Phytomedicine; 2006 May; 13(5):318-23. PubMed ID: 16635739
    [Abstract] [Full Text] [Related]

  • 8. The effect of cimetidine on the steady-state pharmacokinetics and pharmacodynamics of warfarin in humans.
    Niopas I, Toon S, Aarons L, Rowland M.
    Eur J Clin Pharmacol; 1999 Jul; 55(5):399-404. PubMed ID: 10456491
    [Abstract] [Full Text] [Related]

  • 9. Divergent effects of raloxifene HCI on the pharmacokinetics and pharmacodynamics of warfarin.
    Miller JW, Skerjanec A, Knadler MP, Ghosh A, Allerheiligen SR.
    Pharm Res; 2001 Jul; 18(7):1024-8. PubMed ID: 11496940
    [Abstract] [Full Text] [Related]

  • 10. Gender differences in pharmacokinetics of oral warfarin in rats.
    Zhu X, Shin WG.
    Biopharm Drug Dispos; 2005 May; 26(4):147-50. PubMed ID: 15776499
    [Abstract] [Full Text] [Related]

  • 11. [Pharmacokinetic and Pharmacodynamic Analyses of Drug-Drug Interactions between Iguratimod and Warfarin].
    Yamamoto T, Hasegawa K, Onoda M, Tanaka K.
    Yakugaku Zasshi; 2016 May; 136(6):905-11. PubMed ID: 27252068
    [Abstract] [Full Text] [Related]

  • 12. Effects of fesoterodine on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers.
    Malhotra B, Alvey C, Gong J, Li X, Duczynski G, Gandelman K.
    Br J Clin Pharmacol; 2011 Aug; 72(2):257-62. PubMed ID: 21496065
    [Abstract] [Full Text] [Related]

  • 13. Effects of torsemide on pharmacodynamics and pharmacokinetics of warfarin in humans and rats.
    Kim HO, Lee KE, Park HY, Lee NR, Oh BR, Chang BC, Gwak HS.
    J Pharm Pharmacol; 2013 Aug; 65(8):1195-203. PubMed ID: 23837587
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetic and pharmacodynamic interaction of Danshen-Gegen extract with warfarin and aspirin.
    Zhou L, Wang S, Zhang Z, Lau BS, Fung KP, Leung PC, Zuo Z.
    J Ethnopharmacol; 2012 Sep 28; 143(2):648-55. PubMed ID: 22867637
    [Abstract] [Full Text] [Related]

  • 15. Cinacalcet does not affect the pharmacokinetics or pharmacodynamics of warfarin.
    Padhi D, Sullivan JT.
    Drugs R D; 2007 Sep 28; 8(2):79-87. PubMed ID: 17324005
    [Abstract] [Full Text] [Related]

  • 16. Irbesartan does not affect the steady-state pharmacodynamics and pharmacokinetics of warfarin.
    Mangold B, Gielsdorf W, Marino MR.
    Eur J Clin Pharmacol; 1999 Oct 28; 55(8):593-8. PubMed ID: 10541778
    [Abstract] [Full Text] [Related]

  • 17. Effect of aprepitant on the pharmacokinetics and pharmacodynamics of warfarin.
    Depré M, Van Hecken A, Oeyen M, De Lepeleire I, Laethem T, Rothenberg P, Petty KJ, Majumdar A, Crumley T, Panebianco D, Bergman A, de Hoon JN.
    Eur J Clin Pharmacol; 2005 Jul 28; 61(5-6):341-6. PubMed ID: 15983826
    [Abstract] [Full Text] [Related]

  • 18. Effects of cucurbitacin e, a tetracyclic triterpene compound from Cucurbitaceae, on the pharmacokinetics and pharmacodynamics of warfarin in rats.
    Ding T, Zhang Y, Chen A, Tang Y, Liu M, Wang X.
    Basic Clin Pharmacol Toxicol; 2015 May 28; 116(5):385-9. PubMed ID: 25250504
    [Abstract] [Full Text] [Related]

  • 19. Investigation of the effects of herbal medicines on warfarin response in healthy subjects: a population pharmacokinetic-pharmacodynamic modeling approach.
    Jiang X, Blair EY, McLachlan AJ.
    J Clin Pharmacol; 2006 Nov 28; 46(11):1370-8. PubMed ID: 17050802
    [Abstract] [Full Text] [Related]

  • 20. Significant pharmacokinetic and pharmacodynamic interaction of warfarin with the NO-independent sGC activator HMR1766.
    Oberwittler H, Hirschfeld-Warneken A, Wesch R, Willerich H, Teichert L, Lehr KH, Ding R, Haefeli WE, Mikus G.
    J Clin Pharmacol; 2007 Jan 28; 47(1):70-7. PubMed ID: 17192504
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.